Article: ANESTA RECEIVES ACTIQ APPROVAL IN THE UK.

PR Newswire, London, October, 10. This press release is transmitted on behalf of Anesta UK Ltd.

Henley On Thames, England -

Anesta UK Ltd., a wholly-owned subsidiary of Anesta Corp. (Nasdaq: NSTA) announced today that the Medicines Control Agency (MCA) in the United Kingdom has granted a marketing authorisation for Actiq(R) (oral transmucosal fentanyl citrate). Actiq is the first product approved in the UK which is specifically indicated for the management of breakthrough pain in patients already receiving maintenance opioid therapy for chronic pain. (Photo: http://www.newscom.com/cgi-bin/prnh/19990914/ANESTALOGO )

Elan Pharmaceuticals Ltd. (a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!